These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 15804710

  • 21. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF, Stegeman CA, Tervaert JW.
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [Abstract] [Full Text] [Related]

  • 22. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
    Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, Grasselli C, Pavone L, Gregorini G, Monti S, Frassi M, Vecchio F, Corace C, Venegoni E, Buzio C.
    Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
    [Abstract] [Full Text] [Related]

  • 23. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B, Rudolf M, Kozmar A.
    Acta Dermatovenerol Croat; 2004 Sep; 12(4):294-313. PubMed ID: 15588565
    [Abstract] [Full Text] [Related]

  • 24. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E, Ahlquist D, Ullrich S, Gross WL.
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [Abstract] [Full Text] [Related]

  • 25. Antineutrophil cytoplasmic antibodies: clinical characteristics of 10 patients with the perinuclear pattern of immunofluorescence on ANCA testing.
    Ecklund SR, Saluta GS, Agudelo CA, Pisko EJ.
    South Med J; 1992 Feb; 85(2):132-8. PubMed ID: 1738878
    [Abstract] [Full Text] [Related]

  • 26. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
    Damoiseaux J, Dähnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, Egerer K, Hiepe F, van Paassen P, Stöcker W, Schlumberger W, Tervaert JW.
    Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
    [Abstract] [Full Text] [Related]

  • 27. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
    Teixeira L, Mahr A, Jaureguy F, Noël LH, Nunes H, Lefort A, Barry S, Deny P, Guillevin L.
    Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
    [Abstract] [Full Text] [Related]

  • 28. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige J, Pollock W, Trevisin M.
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
    [Abstract] [Full Text] [Related]

  • 29. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A, Nagode B, Rott T, Koselj M, Rozman B, Kaplan-Pavlovcic S, Kosnik M, Petric V, Ferluga D.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):665-70. PubMed ID: 11020953
    [Abstract] [Full Text] [Related]

  • 30. Testing on formalin-fixed neutrophils is less sensitive and specific for small vessel vasculitis, and less sensitive for MPO-ANCA, than most ELISAs.
    Pollock W, Trevisin M, Savige J, Australasian ANCA Study Group.
    J Immunol Methods; 2008 Dec 31; 339(2):141-5. PubMed ID: 18823991
    [Abstract] [Full Text] [Related]

  • 31. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
    Nakano H, Ozaki S.
    Rinsho Byori; 2010 May 31; 58(5):480-9. PubMed ID: 20560457
    [Abstract] [Full Text] [Related]

  • 32. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
    Villalta D, Tonutti E, Tampoia M, Bizzaro N, Papisch W, Tozzoli R, Stella S.
    Clin Chem Lab Med; 2004 May 31; 42(10):1161-7. PubMed ID: 15552276
    [Abstract] [Full Text] [Related]

  • 33. [Autoantibodies associated with vasculitis].
    Aotsuka S.
    Nihon Rinsho; 1994 Aug 31; 52(8):2029-33. PubMed ID: 7933581
    [Abstract] [Full Text] [Related]

  • 34. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.
    Chen M, Yu F, Wang SX, Zou WZ, Zhang Y, Zhao MH, Wang HY.
    Nephrol Dial Transplant; 2007 Jan 31; 22(1):139-45. PubMed ID: 16980322
    [Abstract] [Full Text] [Related]

  • 35. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
    Vermeersch P, Vervaeke S, Blockmans D, van Hoovels L, Mariën G, Vanmaele H, Bossuyt X.
    Clin Chim Acta; 2008 Nov 31; 397(1-2):77-81. PubMed ID: 18708041
    [Abstract] [Full Text] [Related]

  • 36. Distinct differences in autoantigen specificity of anti-neutrophil cytoplasm antibodies in systemic vasculitides and other inflammatory diseases.
    Wiik A, Brimnes J, Heegaard NH.
    Isr Med Assoc J; 1999 Sep 31; 1(1):4-7. PubMed ID: 11370121
    [Abstract] [Full Text] [Related]

  • 37. Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist.
    Gal AA, Velasquez A.
    Mod Pathol; 2002 Mar 31; 15(3):197-204. PubMed ID: 11904336
    [Abstract] [Full Text] [Related]

  • 38. Autoimmunity in kidney diseases.
    Kettritz R.
    Scand J Clin Lab Invest Suppl; 2008 Mar 31; 241():99-103. PubMed ID: 18569975
    [Abstract] [Full Text] [Related]

  • 39. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
    Bosch X, Llena J, Collado A, Font J, Mirapeix E, Ingelmo M, Muñoz-Gómez J, Urbano-Márquez A.
    J Rheumatol; 1995 Nov 31; 22(11):2038-45. PubMed ID: 8596141
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.